Swiss Pharma Nigeria Limited (SWIPHA) is a Nigerian pharmaceutical company engaged in the manufacturing, marketing, and distribution of pharmaceutical products. Established in Nigeria in 1976, the company serves healthcare providers, pharmaceutical distributors, government institutions, and private-sector customers through its range of medicines and healthcare products.

SWIPHA’s product portfolio covers several therapeutic categories, including antimalarials, antibacterials, analgesics, anti-inflammatory medicines, anthelmintics, and other pharmaceutical preparations. Its products include recognised brands such as Arenax Plus, Dart, and Clabetic.

Located in Agege, Lagos State, SWIPHA operates within Nigeria’s pharmaceutical industry, supporting the supply of medicines to the healthcare market. The company’s activities include pharmaceutical manufacturing, product marketing, and distribution, with a focus on meeting healthcare product needs.

Through its pharmaceutical operations and distribution activities, Swiss Pharma Nigeria Limited contributes to the availability of medicines for use under appropriate medical guidance. The company serves a range of customers and stakeholders within the pharmaceutical supply chain, including healthcare professionals, distributors, institutions, and other authorised buyers.

SWIPHA is a relevant business contact for organisations and professionals seeking information about pharmaceutical products, distribution opportunities, and its portfolio of healthcare solutions in Nigeria.

OUR PRODUCTS AND SERVICES

1. Pharmaceutical Manufacturing

SWIPHA is involved in the manufacturing of pharmaceutical products for different therapeutic applications, supporting the supply of medicines to the Nigerian healthcare market.

2. Antimalarial Medicines

The company’s product range includes antimalarial medicines such as Arenax Plus and Dart formulations. Product selection and use should follow approved product information and guidance from qualified healthcare professionals.

3. Antibacterial Medicines

SWIPHA’s pharmaceutical portfolio includes antibacterial products intended for appropriate clinical use under the direction of qualified healthcare professionals.

4. Medicines for Pain and Inflammation

The company’s therapeutic categories include analgesic and anti-inflammatory medicines designed for relevant healthcare needs.

5. Medicines for Other Therapeutic Needs

SWIPHA’s portfolio includes products across additional therapeutic categories, such as anthelmintics and medicines for other healthcare applications.

6. Pharmaceutical Marketing and Distribution

The company undertakes pharmaceutical marketing and distribution activities to support the availability of its products to relevant customers and distribution channels.

WHY CHOOSE SWISS PHARMA NIGERIA LIMITED?

  • Established Industry Presence: Operating in Nigeria’s pharmaceutical sector since 1976.
  • Diverse Pharmaceutical Portfolio: Products covering multiple therapeutic categories.
  • Manufacturing and Marketing Operations: Involvement in pharmaceutical production, marketing, and distribution.
  • Recognised Product Brands: Products including Arenax Plus, Dart, and Clabetic.
  • Healthcare Market Focus: Serving stakeholders within Nigeria’s pharmaceutical and healthcare supply chain.

INDUSTRIES AND CUSTOMERS SERVED

SWIPHA’s business activities are relevant to:

  • Hospitals and healthcare institutions
  • Pharmacies and pharmaceutical retailers
  • Pharmaceutical wholesalers and distributors
  • Healthcare professionals
  • Public-sector healthcare procurement organisations
  • Private-sector healthcare providers
  • Pharmaceutical supply-chain businesses